Global  

Moderna

American biotechnology company

Moderna    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Moderna: American biotechnology company
Moderna is an American biotechnology company focused on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA (mRNA). It is headquartered in Cambridge, Massachusetts. The Moderna technology platform is to insert synthetic mRNA into living cells that would reprogram the cells to develop immune responses, rather than being created externally and injected as with conventional medicines. It is a novel technique abandoned by several large pharmaceutical and biotechnology companies that were unable to overcome the side effects of inserting RNA into cells. As of May 2020, no mRNA drug has been approved for human use.

0
shares
ShareTweetSavePostSend
 

Moderna shares jump on U.S. vaccine deal [Video]

Moderna shares jump on U.S. vaccine deal

Shares of Moderna jumped before paring their gains Wednesday after analysts said a $1.5 billion coronavirus vaccine supply agreement with the U.S. government could lead to similar deals with other..

Credit: Reuters Studio     Duration: 01:09Published
Dow Jumps 270 Points [Video]

Dow Jumps 270 Points

On Wednesday, US stocks rose. Investors reacted to positive coronavirus vaccine news. Shares of Moderna spiked after President Trump announced the US government will by 100 million doses of its..

Credit: Wochit News     Duration: 00:25Published
Trump inks Moderna deal for 100 mln vaccine doses [Video]

Trump inks Moderna deal for 100 mln vaccine doses

The United States has penned an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential COVID-19 vaccine, U.S. President Donald Trump said on Tuesday.

Credit: Reuters Studio     Duration: 01:29Published
Chinese hackers targeted vaccine firm Moderna [Video]

Chinese hackers targeted vaccine firm Moderna

Hackers linked to China's government targeted biotech company Moderna Inc, a leading U.S.-based coronavirus vaccine research developer, earlier this year in a bid to steal valuable data, according to a..

Credit: Reuters Studio     Duration: 01:36Published
First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US [Video]

First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US

The experimental vaccine, developed by Moderna and the National Institute of Allergy and Infectious Diseases, began Phase 3 trials on Monday.

Credit: Cover Video STUDIO     Duration: 01:04Published
Moderna's COVID vaccine enters late-stage trial [Video]

Moderna's COVID vaccine enters late-stage trial

Moderna said on Monday it has started a U.S. government-backed late-stage trial for its COVID-19 vaccine candidate, the first to be implemented under the Trump administration's Operation Warp Speed..

Credit: Reuters Studio     Duration: 00:55Published
Possible COVID-19 Vaccine Shown To Induce Strong Immune Response [Video]

Possible COVID-19 Vaccine Shown To Induce Strong Immune Response

Moderna has announced that a COVID-19 vaccine it is developing has shown promise. The U.S. biotech company says its vaccine has induced a "rapid and strong" immune response against the virus. According..

Credit: Wochit News     Duration: 00:32Published
Early Trials For Coronavirus Vaccine Show "Promise" [Video]

Early Trials For Coronavirus Vaccine Show "Promise"

A COVID-19 vaccine has been found to induce immune responses in some volunteers. The vaccine was developed by Moderna and the National Institutes of Health reports CNN. Immune responses were detected..

Credit: Wochit News     Duration: 00:42Published
Early results show Moderna vaccine is safe [Video]

Early results show Moderna vaccine is safe

Moderna's experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday. Libby..

Credit: Reuters Studio     Duration: 01:35Published
Sanofi eyes vaccine approval by early 2021 [Video]

Sanofi eyes vaccine approval by early 2021

French drugmaker Sanofi expects to get approval for the potential coronavirus vaccine it is developing with GlaxoSmithKline by the first half of next year. Francis Maguire reports.

Credit: Reuters Studio     Duration: 01:13Published

You Might Like


Moderna's virus vaccine costs far more than rival treatments

Drugmaker is charging $32 to $37 for initial doses, more than triple the cost of other vaccines being tested.
CBS News - Published

We can’t skip steps on the road to a COVID-19 vaccine

we can’t skip steps on the road to a covid-19 vaccine
Photo by Blake Nissen for The Boston Globe via Getty Images The pharmaceutical company Moderna started the last, longest step in the process of testing its COVID-19 vaccine candidate at the end of..
The Verge - Published

Poll: If the vaccine is approved, will people actually take it?

poll: if the vaccine is approved, will people actually take it?
There’s been plenty of progress lately in the hunt for a viable vaccine to protect people from the novel coronavirus. Both the Oxford vaccine and the Moderna version have entered...
WorldNews - Published

Moderna Vaccine Test in Monkeys Shows Promise

This coronavirus vaccine developed by government researchers and Moderna enabled the animals to quickly clear the infection from their lungs.
NYTimes.com - Published

Detroit health system seeks vaccine study subjects

A Detroit-area hospital system is looking for up to 5,000 volunteers for a COVID-19 vaccine study. Henry Ford Health System is working with the National Institutes of Health and Moderna Inc., with..
USATODAY.com - Published

Largest COVID-19 vaccine study underway in US

The world's biggest COVID-19 vaccine test got underway Monday with the first of 30,000 planned volunteers. The experimental vaccine is made by the National Institutes of Health and Moderna Inc. It's..
USATODAY.com - Published

Some Vaccine Makers Say They Plan to Profit From Coronavirus Vaccine

Moderna, which is receiving $483 million from the U.S. government, told lawmakers it would not sell its vaccine at cost. Pfizer has said it would also profit, but has so far taken no government money.
NYTimes.com - Published

Covid-19 vaccine developed by US biotech firm Moderna enters final stage trial

covid-19 vaccine developed by us biotech firm moderna enters final stage trial
US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27, to test how well it protects people in the real world. ......
WorldNews - Published

Moderna's COVID vaccine candidate appears to be safe and provide some immunity, new data from early trial shows

It's too early to say if the vaccine candidate can protect someone from the coronavirus that causes COVID-19, but early trials are encouraging.
USATODAY.com - Published

Moderna rally loses steam over COVID-19 vaccine worries

Shares of biotechs racing to make coronavirus vaccines, including Moderna Inc , fell about 10% on Wednesday, as investor concerns grew about the prospects of the experimental products that are still in..
Reuters - Published

How Upbeat Vaccine News Fueled a Stock Surge, and an Uproar

The desperate hunt for treatments and vaccines has changed how researchers, regulators, drug companies like Moderna, investors and journalists do their jobs.
NYTimes.com - Published

S&P stumbles as Moderna sinks on report questioning trial results

The S&P 500 closed lower on Tuesday, as investors focused on a report questioning Moderna's recent coronavirus vaccine early-stage trial results, wiping out modest gains on the benchmark index in the..
Reuters - Published

This Professor Was One of the First Investors in Vaccine-Maker Moderna. He’s Now Worth Nearly $1 Billion

this professor was one of the first investors in vaccine-maker moderna. he’s now worth nearly $1 billion
Another early investor of Moderna is on the cusp of owning a stake worth at least $1 billion after the biotech firm reported encouraging early trial results for an experimental Covid-19 vaccine. The..
WorldNews - Published

Coronavirus Briefing: What Happened Today

A vaccine produced by Moderna appeared to be safe and effective in its first human trial.
NYTimes.com - Published

Coronavirus vaccine from Moderna appears safe, shows promise in data from eight people

Moderna Inc's experimental COVID-19 vaccine, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, according to very early data released by..
Reuters - Published

Moderna's possible coronavirus vaccine delivers preliminary but promising data

Moderna and Oxford COVID-19 vaccine candidates have shown promise according to new data -- but it's very preliminary.
USATODAY.com - Published

Moderna's COVID-19 vaccine shows early promise; shares soar

Early data from Moderna Inc's COVID-19 vaccine, the first to be tested in the United States, showed that it produced protective antibodies in a small group of healthy volunteers, the company said on..
Reuters - Published

Stocks rebound as positive Moderna vaccine trial boosts optimism for economic recovery

Stocks bounced back Monday on optimism the U.S. economy may start to recover from the coronavirus pandemic after drugmaker Moderna released promising early results for a vaccine.
USATODAY.com - Published

Futures jump on promising data for COVID-19 vaccine

U.S. stocks futures jumped on Monday after Moderna Inc said its experimental vaccine for COVID-19 showed promise in early trials and that it was looking to advance the vaccine into late-stage trials in..
Reuters - Published

Moderna Gets OK to Start Larger Trial for a Coronavirus Vaccine

The company announced that the Food and Drug Administration had cleared its application to proceed to a clinical trial involving about 600 people.
NYTimes.com - Published

J&J, Moderna sign deals with U.S. to produce huge quantity of possible coronavirus vaccines

The U.S. government has cut deals with Johnson & Johnson and Moderna Inc and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines..
Reuters - Published

Drugmakers chase vaccine as coronavirus spreads globally

The National Institutes of Health has partnered with a Boston-area company, Moderna, on a vaccine targeting the novel coronavirus.
USATODAY.com - Published

Lovers of Moderna skeletons holding hands were both men

The male skeletons, buried in Roman times, have been holding hands for around 1,500 years.
BBC News - Published